Last updated on July 2018

Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy


Brief description of study

The purpose of this study is to determine whether FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.

Clinical Study Identifier: NCT02720744

Contact Investigators or Research Sites near you

Start Over

Mayo Clinic Hospital

Phoenix, AZ United States
  Connect »

SDS Clinical Trials Inc

Orange, CA United States
  Connect »

Stanford Sleep Medicine

Redwood City, CA United States
  Connect »

Colorado Sleep Institute

Boulder, CO United States
  Connect »

Clinical Research Group of St Petersburg

Saint Petersburg, FL United States
  Connect »

FL Pediatric REsearch Institute

Winter Park, FL United States
  Connect »

NeuroTrials Research Inc

Atlanta, GA United States
  Connect »

Fort Wayne Neurological Center

Fort Wayne, IN United States
  Connect »

Kentucky Research Group

Louisville, KY United States
  Connect »

Research Carolina of Huntersville

Huntersville, NC United States
  Connect »

Geisinger Medical CEnter

Danville, PA United States
  Connect »

SleepMed Of South Carolina

Columbia, SC United States
  Connect »

Sleep Therapy Research Center

San Antonio, TX United States
  Connect »

Sound Sleep Health

Kirkland, WA United States
  Connect »

CHU Michallon

Grenoble, France
  Connect »

Hephata Klinik

Schwalmstadt, Germany
  Connect »

Somni bene GmbH

Schwerin, Germany
  Connect »

Klinik Barmelweid

Barmelweid, Switzerland
  Connect »

Guy's Hospital

London, United Kingdom
  Connect »

Paula Schweitzer

Chesterfield, MO United States
  Connect »

Joseph Ojile, MD

Saint Louis, MO United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.